Dr. Liu is an Investigator at Schepens Eye Research Institute at Mass. Eye and Ear, whose research focuses on developing a potential therapy for meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED) in the world. She also participates in research related to corneal would-healing, glaucoma, and the vitreous. She published several articles with more in preparation, and won a competitive Young Investigator Travel Award to the 7th International Conference on the Tear Film and Ocular Surface (TFOS): Basic Science and Clinical Relevance in Taormina, Sicily in 2013. She has been invited to give research presentations at national and international meetings and conferences. She was selected to serve in the international TFOS Dry Eye Workshop II, which will create and publish a global consensus on the definition, classification, epidemiology, pathophysiology diagnosis and treatment of DED.
For a full publication list, please see her CV.
Liu Y, Kam WR, Sullivan DA. Influence of omega 3 and 6 fatty acids on human meibomian gland epithelial cells. Cornea 2016;35:1122-1126.
Liu Y, Kam WR, Ding J, Sullivan DA. Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate meibomian gland epithelial cell differentiation? Cornea 2015;34:342-346.
Liu Y, Ding J. The Combined Effect of Azithromycin and Insulin-Like Growth Factor-1 on Cultured Human Meibomian Gland Epithelial Cells. Invest Ophthalmol Vis Sci 2014Mar;55(9):5596.
Liu Y, Kam WR, Ding J, Sullivan DA. One man's poison is another man's meat: Using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology. 2014;320:1–5.
Liu Y, Kam WR, Ding J, Sullivan DA. Effect of azithromycin on lipid accumulation in immortalized human meibomian gland epithelial cells. JAMA Ophthalmology 2014; 132:226-228.
View a complete list of publications on pubmed.gov>>